Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 44 results.
User Information
Export Records
  1. 1.   Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
  2. Guerra-de-Blas, Paola Del Carmen; Marines-Price, Rubria; Milman, Olga; Deal,Danae; Marchand,Jon; Linton,Jessica; Meger, Sue; Rule, John; Holland, Thomas L; Kitonsa, Jonathan; Delph, Yvette
  3. Journal of Clinical and Translational Science. 2024, Oct 15; 8(1): e157.
  1. 2.   RNF219 attenuates global mRNA decay through inhibition of CCR4-NOT complex-mediated deadenylation
  2. Poetz, Fabian; Corbo,Joshua; Levdansky,Yevgen; Spiegelhalter, Alexander; Lindner, Doris; Magg, Vera; Lebedeva, Svetlana; Schweiggert, Jorg; Schott, Johanna; Valkov,Eugene; Stoecklin, Georg
  3. Nature Communications. 2021, Dec 9; 12(1):
  1. 3.   The dystonia gene THAP1 controls DNA double-strand break repair choice
  2. Shinoda, Kenta; Zong, Dali; Callen, Elsa; Wu, Wei; Dumitrache, Lavinia C.; Belinky, Frida; Chari,Raj; Wong, Nancy; Ishikawa, Momoko; Stanlie, Andre; Multhaupt-Buell, Trisha; Sharma, Nutan; Ozelius, Laurie; Ehrlich, Michelle; McKinnon, Peter J.; Nussenzweig, Andre
  3. MOLECULAR CELL. 2021, Jun 17; 81(12): 2611-2624.e10.
  1. 4.   Type 2 immunity induced by bladder extracellular matrix enhances corneal wound healing
  2. Wang, Xiaokun; Chung, Liam; Hooks, Joshua; Maestas, David R. Jr Jr; Lebid, Andriana; Andorko, James; Huleihel, Luai; Chin, Alexander F.; Wolf,Matthew; Remlinger, Nathaniel T.; Stepp, Mary Ann; Housseau, Franck; Elisseeff, Jennifer H.
  3. SCIENCE ADVANCES. 2021, Apr; 7(16):
  1. 5.   Annexin 1 Released by Necrotic Human Glioblastoma Cells Stimulates Tumor Cell Growth through the Formyl Peptide Receptor 1
  2. Yang, Y.; Liu, Y.; Yao, X. H.; Ping, Y. F.; Jiang, T.; Liu, Q.; Xu, S. L.; Huang, J.; Mou, H. W.; Gong, W. H.; Chen, K. Q.; Bian, X. W.; Wang, J. M.
  3. American Journal of Pathology. 2011, Sep; 179(3): 1504-1512.
  1. 6.   Regulation of microtubule-based microtubule nucleation by mammalian polo-like kinase 1
  2. Johmura, Y.; Soung, N. K.; Park, J. E.; Yu, L. R.; Zhou, M.; Bang, J. K.; Kim, B. Y.; Veenstra, T. D.; Erikson, R. L.; Lee, K. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(28): 11446-11451.
  1. 7.   Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
  2. Kang, Z. G.; Chen, J. J.; Yu, Y. K.; Li, B.; Sun, S. Y.; Zhang, B. L.; Cao, L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3181-3192.
  1. 8.   Gene from a Psoriasis Susceptibility Locus Primes the Skin for Inflammation
  2. Wolf, R.; Mascia, F.; Dharamsi, A.; Howard, O. M. Z.; Cataisson, C.; Bliskovski, V.; Winston, J.; Feigenbaum, L.; Lichti, U.; Ruzicka, T.; Chavakis, T.; Yuspa, S. H.
  3. Science Translational Medicine. 2010, Dec; 2(61): 10.
  1. 9.   A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis
  2. Venteicher, A. S.; Abreu, E. B.; Meng, Z. J.; McCann, K. E.; Terns, R. M.; Veenstra, T. D.; Terns, M. P.; Art, i
  3. Science. 2009, Jan 30; 323(5914): 644-648.
  1. 10.   Two Distinct Motifs within the p53 Transactivation Domain Bind to the Taz2 Domain of p300 and Are Differentially Affected by Phosphorylation
  2. Jenkins, L.; Yamaguchi, H.; Hayashi, R.; Cherry, S.; Tropea, J. E.; Miller, M.; Wlodawer, A.; Appella, E.; Mazur, S. J.
  3. Biochemistry. 2009 48(6): 1244-1255.
  1. 11.   Chemotactic activity of S100A7 (psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15
  2. Wolf, R.; Howard, O.; Dong, H. F.; Voscopoulos, C.; Boeshans, K.; Winston, J.; Divi, R.; Gunsior, M.; Goldsmith, P.; Ahvazi, B.; Chavakis, T.; Oppenheim, J. J.; Yuspa, S. H.
  3. Journal of Immunology. 2008 181(2): 1499-1506.
  1. 12.   Human T-cell leukemia virus type 1 tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes
  2. Wencker, M.; Sausse, C.; Derse, D.; Gazzolo, L.; Dodon, M. D.
  3. Journal of Virology. 2007, Jan; 81(1): 301-308.
  1. 13.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 14.   Suppression of p65 phosphorylation coincides with inhibition of I kappa B alpha polyubiquitination and degradation
  2. Hu, J.; Haseebuddin, M.; Young, M.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 274-284.
  1. 15.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 16.   Coactivators and corepressors of NF-kappa B in I kappa Beta alpha gene promoter
  2. Gao, Z. G.; Chiao, P.; Zhang, X.; Zhang, X. H.; Lazar, M. A.; Seto, E.; Young, H. A.; Ye, J. P.
  3. Journal of Biological Chemistry. 2005, JUN 3; 280(22): 21091-21098.
  1. 17.   Cutting edge: Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex
  2. Medvedev, A. E.; Thomas, K.; Awomoyi, A.; Kuhns, D. B.; Gallin, J. I.; Li, X. X.; Vogel, S. N.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 6587-6591.
  1. 18.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
  1. 19.   Myosin-1a is critical for normal brush border structure and composition
  2. Tyska, M. J.; Mackey, A. T.; Huang, J. D.; Copeland, N. G.; Jenkins, N. A.; Mooseker, M. S.
  3. Molecular Biology of the Cell. 2005, MAY; 16(5): 2443-2457.
  1. 20.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 21.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
  1. 22.   Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappa B activation and transformation in resistant JB6 cells
  2. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H.
  3. Carcinogenesis. 2004, OCT; 25(10): 1991-2003.
  1. 23.   Regulation of amphiphysin1 by mitogen-activated protein kinase - Its significance in nerve growth factor receptor-mediated endocytosis
  2. Shang, W. H.; Adachi, Y.; Nakamura, A.; Copeland, T.; Kim, S. R.; Kamata, T.
  3. Journal of Biological Chemistry. 2004, SEP 24; 279(39): 40890-40896.
  1. 24.   Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages
  2. Bosco, M. C.; Puppo, M.; Pastorino, S.; Mi, Z. H.; Melillo, G.; Massazza, S.; Rapisarda, A.; Varesio, L.
  3. Journal of Immunology. 2004 172(3): 1681-1690.
  1. 25.   Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: Role of p38 mitogen-activated protein kinase and NF-kappa B
  2. Matsuyama, W.; Wang, L. H.; Farrar, W. L.; Faure, M.; Yoshimura, T.
  3. Journal of Immunology. 2004 172(4): 2332-2340.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel